Tom Essaye Quoted in Barron’s on October 2, 2020
For now, though, all eyes are on Washington. “For the next several days reports of President Trump’s health will…” writes The Sevens Report’s Tom Essaye. Click here to read the full article.
For now, though, all eyes are on Washington. “For the next several days reports of President Trump’s health will…” writes The Sevens Report’s Tom Essaye. Click here to read the full article.
What’s in Today’s Report:
Futures are moderately higher again following better than expected economic data overnight.
Chinese economic data was solid as August Retail Sales (0.5% vs. (E) 0.1%) and Industrial Production (5.6% vs. (E) 5.1%) both beat estimates. In Europe, the German ZEW expectations index also beat estimates (77.4 vs. (E) 69.5). Bottom line, the data implies the global economic recovery is still on going.
On the vaccine front, headlines were more mixed as the resumption of the AZN trial in the U.S. isn’t expected until the middle of this week, at the earliest. But, markets still very much expect a vaccine to be approved by Election Day and distributed by year-end (and that remains a very optimistic assumption).
Today the looming Fed meeting (tomorrow) should keep the markets generally quiet, although we do get the September Empire Manufacturing Survey (E: 6.5), which is the first data point for September. If it’s stronger than expected, that will further confirm the U.S. economy remains resilient despite no more stimulus, and that will help support the early rally in futures.
“Let me be clear: The only reason we do not have a stimulus bill passed yet is because the economy and the markets are performing…” said Tom Essaye, founder of The Sevens Report. Click here to read the full article.
Investors are still expecting another stimulus package will eventually get passed: “The market still wants, and very much expects, an actual stimulus bill to be signed…” according to Tom Essaye, editor of the Sevens Report. Click here to read the full article.
What’s in Today’s Report:
S&P 500 futures are approaching record highs this morning amid news that Russia has approved a COVID-19 vaccine while investors remain optimistic for a U.S. stimulus deal.
In a televised meeting, Russian President, Vladimir Putin, stated that Moscow’s Gamaleya Institute successfully developed a “safe and effective” coronavirus vaccine ready to move to a Phase 3 trial, sparking risk-on money flows.
Economically, both the German ZEW Survey and the NFIB Small Business Optimism Index largely met estimates and importantly did not alter the narrative that the broader global economic recovery remains underway.
Today, there is one economic report: PPI (E: 0.3%) and one Fed official is scheduled to speak: Daly (12:00 p.m. ET) but neither should move markets as investors will be keenly focused on the details surrounding the Russian coronavirus vaccine as well as any new progress towards a deal on the next U.S. stimulus bill.
What’s in Today’s Report:
Futures are little changed as markets look past President Trump’s executive orders on economic stimulus following an otherwise quiet weekend.
With stimulus talks again at an impasse, President Trump issued several executive orders over the weekend to provide economic stimulus, including $300/week in federal unemployment and a payroll tax deferral.
But, for a multitude of reasons (legal and otherwise) none of these actions will have any immediate economic impact, so the market still expects a stimulus bill to be passed (but now in the coming weeks, not immediately).
Today there’s one labor market number, JOLTS (E: 5.288M), but that shouldn’t move markets, and instead focus will be on stimulus. Today, the key is that both the Democrats and Republicans signal they are going to continue negotiations on the stimulus bill. If the rhetoric implies the talks have stalled completely, that that will likely pressure stocks.
“The bottom line is that if we do see real disappointment in stimulus or the vaccine, then a 10% correction is the likely best-case scenario, and it’ll come…” said Tom Essaye of The Sevens Report, in a note. Click here to read the full article.
What’s in Today’s Report:
Futures are marginally higher following decent economic data combined with some mild progress on stimulus hopes.
Global manufacturing PMIs were generally better than expected as the Chinese PMI rose to 52.8 vs. (E) 51.1 while the EU number also beat expectations (51.8 vs. (E) 51.1).
On the stimulus front, both parties acknowledged some progress on negotiations, but they remained far apart.
Today focus will be on the ISM Manufacturing PMI (E: 53.5) and the market needs/wants a strong number here to help refute the growing list of indicators that imply the economic recovery is pausing/stalling.
Regarding stimulus, headlines will move the market this week but more broadly, investors are expecting some significant progress by the end of the week. If that progress doesn’t occur, that will become a headwind on stocks.
Finally, there are also two Fed speakers today, Bullard (12:30 p.m.ET) and Evans (2:00 p.m. ET), but neither should move markets.
“To be clear, from an actual policy standpoint, it’s universally expected that the Fed won’t make any changes to 1) Rates…” wrote Tom Essaye, editor of the Sevens Report. Click here to read the full article.
What’s in Today’s Report:
Futures are marginally higher ahead of the Fed as markets bounce from Tuesday’s declines thanks to decent earnings.
Earnings after the bell were decent as AMD and SBUX both rallied, although Visa (V) made cautious comments on consumer spending late in Q2, which again implies we’re seeing a potential stall in the economic recovery.
Economically there were no notable reports overnight.
Today the key event is the FOMC Decision (E: No Change to Rates or QE) and Fed Chair Press Conference at 2:30 p.m. ET. Again, if there’s going to be a surprise from the Fed today (which is unlikely) it’s going to come from the press conference – so we’ll be watching.
4880 Donald Ross Rd., Suite 210
Palm Beach Gardens, FL 33418
info@sevensreport.com
(561) 408-0918